Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus

被引:0
作者
Juan Huang
Jun-Xu Gu
Kun Wang
Ai-Min Zhang
Ting-Ting Hong
Shan-Shan Li
Xiao-Qin Yao
Ming Yang
Yue Yin
Na Zhang
Ming Su
Jia-Jia Hu
Xue-Zhi Zhang
Mei Jia
机构
[1] Peking University International Hospital,Department of traditional Chinese medicine
[2] Peking University People’s Hospital,Department of Clinical Laboratory
[3] Central South University,Department of Clinical Laboratory, Xiangya Hospital
[4] Peking University International Hospital,Department of Clinical Laboratory
来源
Diabetology & Metabolic Syndrome | / 15卷
关键词
PCSK9; T2DM; Coronary heart disease; Cardiovascular events;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease
    Alireza Farrokhian
    Mina Mahmoodian
    Fereshteh Bahmani
    Elaheh Amirani
    Rana Shafabakhsh
    Zatollah Asemi
    Biological Trace Element Research, 2020, 194 : 313 - 320
  • [42] ASSOCIATION OF ELEVATED SERUM URIC-ACID WITH CORONARY HEART-DISEASE IN DIABETES-MELLITUS
    RATHMANN, W
    HAUNER, H
    DANNEHL, K
    GRIES, FA
    DIABETES & METABOLISM, 1993, 19 (1BIS): : 159 - 166
  • [43] Prognostic value of PCSK9 levels in patients with acute coronary syndromes
    Gencer, Baris
    Montecucco, Fabrizio
    Nanchen, David
    Carbone, Federico
    Klingenberg, Roland
    Vuilleumier, Nicolas
    Aghlmandi, Soheila
    Heg, Dik
    Raeber, Lorenz
    Auer, Reto
    Jueni, Peter
    Windecker, Stephan
    Luescher, Thomas F.
    Matter, Christian M.
    Rodondi, Nicolas
    Mach, Francois
    EUROPEAN HEART JOURNAL, 2016, 37 (06) : 546 - 553
  • [44] Diabetes mellitus and coronary heart disease
    Wilson, PWF
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : S89 - S100
  • [45] Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes
    Walus-Miarka, Malgorzata
    Kapusta, Maria
    Miarka, Przemyslaw
    Kawalec, Ewa
    Idzior-Walus, Barbara
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [46] Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy
    Kim, Hye Jeong
    Byun, Dong Won
    Suh, Kyoil
    Yoo, Myung Hi
    Park, Hyeong Kyu
    DIABETES & METABOLISM JOURNAL, 2018, 42 (06) : 513 - 518
  • [47] The Burden of Impaired Serum Albumin Antioxidant Properties and Glyco-Oxidation in Coronary Heart Disease Patients with and without Type 2 Diabetes Mellitus
    Piarulli, Francesco
    Banfi, Cristina
    Brioschi, Maura
    Altomare, Alessandra
    Ragazzi, Eugenio
    Cosma, Chiara
    Sartore, Giovanni
    Lapolla, Annunziata
    ANTIOXIDANTS, 2022, 11 (08)
  • [48] Carvedilol effectiveness in complex treatment of patients with arterial hypertension, coronary heart disease, and Type 2 diabetes mellitus
    Shakirova, R. M.
    Galyavich, A. S.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (05): : 25 - 29
  • [49] Effect of Blood Glucose Level of Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease on the Hypercoagulability and Thromboembolism
    Cao, Qing
    Jiao, Wei
    Lu, Huihui
    Zhang, Jing
    Ren, Meiling
    Xu, Yan
    Hu, Shuyang
    PAKISTAN JOURNAL OF ZOOLOGY, 2024, 56 (02) : 695 - 701
  • [50] Effects of aerobic and anaerobic exercise on glucose tolerance in patients with coronary heart disease and type 2 diabetes mellitus
    Schwaab, Bernhard
    Kafsack, Friderike
    Markmann, Edith
    Schuett, Morten
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2020, 9 (01) : 3 - 8